[Tissue binding of orally administered bismuth in the rat. Effect of the digestive microbial flora]. 1982

R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet

Strains of E. coli and Str. faecalis, which do not darken in the presence of Bismuth in vitro, and which had been previously isolated from faeces of patients having presented bismuthic myoclonic encephalopathy, were implanted in the digestive tract of axenic rats. Then these monoxenic rats were treated orally for 15 days with bismuth subnitrate (0,24 millimoles = 50 mg/animal/day) and sacrificed on day 16. At this time, levels of bismuth in blood, brain, kidney and femur from these rats did not significantly differ from those obtained from axenic rats or monoxenic rats implanted with the homologous bacterial strains which darken in the presence of bismuth. Conversely, under the same conditions, levels of bismuth in kidney, muscle and femur were significantly lower in holoxenic rats than in axenic rats. Levels of bismuth in kidney and femur were also significantly lower in holoxenic rats than in monoxenic rats implanted with one of the four bacterial strains mentioned above.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D001729 Bismuth A metallic element that has the atomic symbol Bi, and atomic number 83. Its principal isotope is Bismuth 209.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
January 1980, Clinical and experimental pharmacology & physiology,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
April 1978, Gastroenterologie clinique et biologique,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
January 1976, Therapie,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
December 1966, Journal of the American Geriatrics Society,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
September 1949, Journal of bacteriology,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
September 1949, Journal of bacteriology,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
August 1986, The Japanese journal of antibiotics,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
April 2015, Vnitrni lekarstvi,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
September 1983, Zeitschrift fur Ernahrungswissenschaft,
R Jeanrot, and D Chaleil, and P Allain, and C Papillon, and G Raynaud, and P Bouvet
January 2004, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!